Scott, Eleanor M
Murphy, Helen R.
Myers, Jenny
Saravanan, Ponnusamy
Poston, Lucilla
Law, Graham R
Funding for this research was provided by:
Medical Research Council (MR/T001828/1)
Article History
Received: 27 March 2023
Accepted: 30 June 2023
First Online: 3 August 2023
Declarations
:
: This study will be performed in accordance with the Declaration of Helsinki. It has been approved by Yorkshire & The Humber - Leeds East Research Ethics Committee (reference 20/YH/0011) and approved by the Health Regulation Authority (HRA) for participating NHS organisations in England. Participants will give informed written consent. Participants will not receive feedback on their data during the project; however, they will be offered a summary of the research findings at the end of the study.
: Not applicable.
: HRM sits on the Medtronic European Scientific Advisory Board and reports speaker honoraria from Dexcom, Abbott, Medtronic and Novo Nordisk. EMS reports receiving speaker honoraria from Abbott Diabetes Care and Eli-Lilly. GRL, PS, JM and LP have no interests to declare.